ImmuneWorks' Debt Round

ImmuneWorks raised a round of funding on July 17, 2009.

ImmuneWorks is a clinical stage biotechnology company developing a therapeutic asset for idiopathic pulmonary fibrosis (IPF) and additional fibrotic lung diseases.…

Articles about ImmuneWorks' Debt Round: